Troy Edward Wilson - 27 Sep 2025 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role: President and CEO, Director
Signature: Thomas Doyle, Attorney-in-fact for Troy E. Wilson
Issuer symbol: KURA
Transactions as of: 27 Sep 2025
Net transactions value: -$327,419
Form type: 4
Filing time: 29 Sep 2025, 19:30:04 UTC
Previous filing: 09 Sep 2025
Next filing: 14 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
WILSON TROY EDWARD	President and CEO, Director	C/O KURA ONCOLOGY, INC., 12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO	Thomas Doyle, Attorney-in-fact for Troy E. Wilson	29 Sep 2025	0001589597

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KURA	Common Stock	Award	$0	+182,500	+181%	$0.000000	283,468	27 Sep 2025	Direct
transaction	KURA	Common Stock	Sale	$327,419	-36,615	-13%	$8.94	246,853	29 Sep 2025	Direct	F1
holding	KURA	Common Stock						279,194	27 Sep 2025	by One Fish Two Fish Revocable Trust
holding	KURA	Common Stock						300,000	27 Sep 2025	by Lorax Charitable Remainder Unitrust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares.

Content

Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares.